GABA alleviated obesity-induced increases in fasting blood glucose, improved glucose tolerance and insulin resistance, and improved the serum lipid profile, including decreased TG, TC, and LDL and increased HDL, suggesting that GABA improves insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.